Skip to main content

Table 3 Descriptive analysis of different DAAs treatment regimens received by the studied cases

From: Assessment of carotid atherosclerosis in Egyptian chronic hepatitis C patients after treatment by direct-acting antiviral drugs

  Studied patients
(no. = 80)
No %
SOF/DAC 56 70.0%
SOF/DAC/RBV 24 30.0%
  1. Seventy-seven (96.25%) patients achieved SVR, while 3 (3.75%) patients relapsed